مجله اخلاق پزشکی - علمی پژوهشی

Abbasi M. The role of virtue based ethics in the education and training of medical professional commitment. Medical Ethics 2012; 5(18): 143-160. [Persian]

Tabatabai S, Simforoosh N, Abbasi M. Fundamental Values of Health and Medical Science Education Progress Model in I.R.Iran. Med Ethics J 2019; 13(44): e11.

Zweifel P, Manning WG. Moral hazard and consumer incentives in health care. Handbook of Health Economics. Edited by Culyer AJ, Newhouse JP. 1st ed. Handbook of Health Economics. North Holland: Elsevier; 2000. p.409-459.

Rashidian A. Universal health coverage in Iran. IRAN Health: WHO-Iran Newsletter 2010; 2(6): 2-23.

Wonderling D, Gruen R, Black N. Introduction to health economics. New York: McGraw-Hill International; 2005.

Soofi M, Bazyar M, Rashidian A. Types of moral hazards and its effects on insurance marketing and health system. Hospital 2012; 11(3): 73-80. [Persian]

Keshavarz Haddad G, Zomorodi Anbaji M. Analysis of Adverse Selection and Moral Hazard in Health Insurance of Iran Case Study of Medicine and Paraclinical Services. Tahghighat-e-Eghtesadi 2010; 44(2): 1-25. [Persian]

Hu S. Financing, pricing and utilisation of pharmaceuticals in China: the road to reform. The World Bank. 2010.

Wettermark B, Persson ME, Wilking N, Kalin M, Korkmaz S, Hjemdahl P, et al. Forecasting drug utilization and expenditure in a metropolitan health region. BMC Health Services Research 2010; 10(1): 128-142.

Meng Q, Cheng G, Silver L, Sun X, Rehnberg C, Tomson G. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy and Planning 2005; 20(3): 185-196.

Otoom SA, Sequeira RP. Health care providers' perceptions of the problems and causes of irrational use of drugs in two Middle East countries. International Journal of Clinical Practice 2006; 60(5): 565-570.

Anonymous. Promoting Rational Useof Medicines. WHO Policy Perspectives on Medicines 2002; 5(1): 1-6.

Delpasand K, Nazari Tavakkoli S, Mohammadi Kojidi H. The Relationship between the Pharmacist and the Patient from the Point of View of Ethics and Law. Med Ethics J 2019; 13(44): e6.

Al-Arifi MN. Community pharmacist perception and attitude toward ethical issues at community pharmacy setting in central Saudi Arabia. Saudi Pharmaceutical Journal 2014; 22(4): 315-325.

Getzen TE. Health economics: Fundamentals and flow of funds. New York: John Wiley & Sons; 1997 .

Elahi Manesh M. Hoghooghe keyfari va takhallofatepezeshki. Tehran: Majd; 1387. [Persian]

Dehghan MS, Javidan F, Shamsi-Koushki E, Abbasi M. A thematic and quantitative study of medical ethics articles in Islamic countries of the eastern Mediterranean region of the World Health Organization. Med Ethics J 2013; 7(25): 147-163. [Persian]

Irshaid YM, Al-Homrany MA, Hamdi AA, Adjepon-Yamoah KK, Mahfouz AA. A pharmacoepidemiological study of prescription pattern in outpatient clinics in Southwestern Saudi Arabia. Saudi Medical Journal 2004; 25(12): 1864-1870.

Ghodoosi A, Abedi HA, Mansouri A, Riaziat A. Evaluating the cases of violating the regulations of medical services insurance organization in Isfahan province, Iran. Health Information Management 2012; 9(3): 339-347. [Persian]

Rudman WJ, Eberhardt JS, Pierce W, Hart-Hester S. Healthcare fraud and abuse. Perspectives in Health Information Management, American Health Information Management Association 2009; 6(Fall): 1-36.

Gee J. Mobilizing the honest majority to fight health-sector fraud. Bull World Health Organ 2009; 87(4): 254-255.

Sheikhol-Eslami H, Asefzadeh S. Antibiotics in Qazvin physicians' prescriptions. J Med Faculty, Guilan Uni Med Sci 1999; 8(1): 35-41. [Persian]

Sepehri G, Shamsi M. The quality of prescribing in general practice in Kerman, Iran. International Journal of Health Care Quality Assurance 2005; 18(5): 353-360.

Zareshahi R, Haghdoost A, Asadipour A, Sadeghirad B. Rational Usage of Drug Indices in the Prescriptions of Kerman Medical Practitioners in 2008. Journal of Rafsenjan University of Medical Sciences 2012; 11(6): 523-536. [Persian]

Lundin D. Moral hazard in physician prescription behavior. Journal of Health Economics 2000; 19(5): 639-662.